Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the ...

Delcath Systems announced the exercise of 1.7 million Series E and E1 warrants, resulting in $16.3 million in funding. This financial boost positions Delcath to strengthen its commercialization ...

In this article we are going to take a look at where Delcath Systems Stock (NASDAQ:DCTH) stands. November has been an eventful month so far for the market as the Fed cut rates by a quarter ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced ...

Verition Fund Management LLC lessened its holdings in shares of Delcath Systems, Inc. (NASDAQ:DCTH – Free Report) by 20.4% in ...

MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were lower this morning, with the Dow futures falling over 100 points ...